论文部分内容阅读
目的:对新生儿肺炎患儿采用纳洛酮进行治疗,观察和分析其治疗的临床效果。方法:将我院此次所收治的256例新生儿肺炎患者,按照多中心、随机、平行等方法进行分组,分成对照组和治疗组,各为128例。对照组给患儿采用常规的抗感染、化痰,必要时进行吸氧等对症治疗。治疗组在对照组治疗的基础上,给患儿加用纳洛酮注射液进行肌肉注射治疗。结果:治疗组治疗有效率为97.7%(125/128)明显高于对照组84.4%(108/128),此外,治疗组患者的临床症状改善情况明显优于对照组,差异显著,具有统计学意义(P<0.05)。结论:在临床上,对新生儿肺炎患者采用纳洛酮进行治疗,有效地改善患者的临床症状,促进患者的康复,减轻患者的痛苦,保障患者健康成长,值得在临床上使用。
Objective: To treat children with neonatal pneumonia with naloxone, and to observe and analyze its clinical effect. Methods: 256 cases of neonatal pneumonia admitted in our hospital were divided into control group and treatment group according to multiple centers, randomized and parallel methods, each of which was 128 cases. Control group to children with conventional anti-infection, phlegm, if necessary, oxygen and other symptomatic treatment. Treatment group in the control group based on the treatment of children with naloxone injection for intramuscular injection therapy. Results: The effective rate of the treatment group was 97.7% (125/128), which was significantly higher than that of the control group (84.4%, 108/128). In addition, the improvement of clinical symptoms in the treatment group was significantly better than that in the control group Significance (P <0.05). Conclusion: In clinical practice, naloxone is used to treat neonates with pneumonia, which can effectively improve the clinical symptoms, promote the recovery of patients, alleviate the suffering of patients and ensure the healthy growth of patients. It is worth to be used clinically.